The cumulative detection rates for PSA <0.5 ng/mL and PSA >0.5 ng/mL were 49% (95% CI: 23%–74%) and 86% (95% CI: 78%–93%), respectively.[6] Therefore, PSMA-PET/CT has already gained recognition in the technology domain for the diagnosis of noninvasive PC. The gene discussed is FOLH1; the disease is pachyonychia congenita.